IMCR - Immunocore PLC P/S multiplikatori

Immunocore Corp (IMCR) tovar belgisi

Sotuvlar nisbatidagi narx koeffitsiyenti tomonidan namoyish etilgan tebranishlar Immunocore Holdings plc (IMCR) kompaniyasining immuno-onkologiya sohasidagi nufuzli markaz sifatidagi maqomini ta'kidlaydi. Okulyar melanomaga qarshi inqilobiy davolash usullari va raqobatchilarni chetlatuvchi mustahkam patent himoyasi barqarorlikni ta'minlaydi. 3.50 qiymati parametrning joriy holatini aks ettirib, FDA ning qat'iy talablari va qimmatga tushadigan tadqiqotlar fonida kompaniya sotuvlarining bozor qiymatini baholashga yordam beradi.

IMCR (Immunocore PLC) Narxning daromadga nisbati tarixi 04.07.2022dan 17.11.2026gacha

Immunocore PLC (IMCR) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning umumiy tahlili:Immunocore, IMCR
Immunocore Holdings ishlab chiqargan mahsulot

P/S koeffitsienti bozor kapitalizatsiyasini yillik savdo hajmi bilan bog'laydi, bu esa sof foyda tebranishlarini hisobga olmaydigan biznesni baholash imkonini beradi. Daromad koeffitsiyenti tendentsiyasidagi 3.50 ning joriy qiymati melanoma dori vositasining tijoratlashtirilishiga bo'lgan bozor kutganlarini aks ettiradi, bunda haqiqiy savdo tushumlarining o'sishi Immunocore Holdings plc (IMCR) ning spekulyativ baholashini asta-sekin fundamental barqarorlik va o'z-o'zini ta'minlashga aylantirmoqda.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning daromadga nisbati ImmunityBio Corp IBRX|Janux Therapeutics Inc - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Arcus Corp RCUS|ZYME - Narxning daromadga nisbati|TNGX (tangotx.com) - Kapitalizatsiya va daromad nisbati|Iovance Corp (IOVA) - Narxning daromadga nisbati|Sotuvga nisbatan narx Immatics Corp (IMTX)|Kapitalizatsiyaning daromadga nisbati XNCR|CMPX - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati REPL (Replimune Corp)|Kapitalizatsiyaning sotish hajmiga nisbati LYEL|P/S multiplikatori IPHA (Innate Pharma)|Bozor kapitallashuvining daromadga nisbati PYXS|Compugen Limited - P/S multiplikatori|Sotuvga nisbatan narx IO Biotech Inc.|Sutro Biopharma, Inc. (STRO) - Narxning daromadga nisbati|MiNK Therapeutics, Inc. - Bozor kapitallashuvining daromadga nisbati|HOWL (Werewolf) - P/S multiplikatori|P/S multiplikatori immixbio.com|Narxning daromadga nisbati ALX Oncology Holdings (ALXO)|CUE - Sotuvga nisbatan narx|PDS Biotechnology Corporation - Kapitalizatsiyaning daromadga nisbati|Sonnet BioTherapeutics (SONN) - Sotuvga nisbatan narx|MAIA - Narxning daromadga nisbati|LIMN: Narxning daromadga nisbati|LVTX: P/S multiplikatori|Sotuvga nisbatan narx NextCure, Inc. (NXTC)|LPTX (Leap Tx) - P/S multiplikatori|INTS (Intensity Therapeutics) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Sensei Bio (SNSE)|TOVX (Theriva Biologics) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati gritstonebio.com GRTS|Bozor kapitallashuvining daromadga nisbati KA|NEXI - Narxning daromadga nisbati|Turnstone Biologics Corp. - Kapitalizatsiyaning sotish hajmiga nisbati|VCNX: P/S multiplikatori|Kapitalizatsiya va daromad nisbati HARP